Literature DB >> 4436843

Treating multiple sclerosis with amantadine hydrochloride.

M Schapira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4436843      PMCID： PMC2157366     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN： 0035-8797


× No keyword cloud information.
  2 in total

1.  Amantadine in the treatment of Parkinson's disease.

Authors:  R S Schwab; A C England; D C Poskanzer; R R Young
Journal:  JAMA       Date:  1969-05-19       Impact factor: 56.272

2.  A study of 1-adamantamine hydrochloride during the 1970 Hong Kong influenza epidemic.

Authors:  M Schapira; J S Oxford; A W Galbraith
Journal:  J R Coll Gen Pract       Date:  1971-12
  2 in total
  3 in total

Review 1.  Neurology.

Authors:  A N Gale; J M Gibbs; A H Schapira; P K Thomas
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

2.  Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010.

Authors:  Sharon K Greene; David K Shay; Ruihua Yin; Natalie L McCarthy; Roger Baxter; Michael L Jackson; Steven J Jacobsen; James D Nordin; Stephanie A Irving; Allison L Naleway; Jason M Glanz; Tracy A Lieu
Journal:  Influenza Other Respir Viruses       Date:  2012-06-11       Impact factor: 4.380

3.  Effectiveness of amantadine in reducing relapses in multiple sclerosis.

Authors:  G S Plaut
Journal:  J R Soc Med       Date:  1987-02       Impact factor: 18.000
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.